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Isolation of speciﬁc genomic regions retaining molecular interactions is necessary for their biochemical
analysis. Here, we established a novel method, engineered DNA-binding molecule-mediated chromatin
immunoprecipitation (enChIP), for puriﬁcation of speciﬁc genomic regions retaining molecular interac-
tions. We showed that enChIP using the CRISPR system efﬁciently isolates speciﬁc genomic regions. In
this form of enChIP, speciﬁc genomic regions are immunoprecipitated with antibody against a tag(s),
which is fused to a catalytically inactive form of Cas9 (dCas9), which is co-expressed with a guide RNA
(gRNA) and recognizes endogenous DNA sequence in the genomic regions of interest. enChIP–mass spec-
trometry (enChIP–MS) targeting endogenous loci identiﬁed associated proteins. enChIP using the CRISPR
system would be a convenient and useful tool for dissecting chromatin structure of genomic regions of
interest.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license. 1. Introduction
Function of eukaryotic genome is mediated by molecular com-
plexes in the context of chromatin [1]. Elucidation of molecular
mechanisms of genome functions requires identiﬁcation of compo-
nents mediating the genome function. However, biochemical nat-
ure of chromatin domains is poorly understood, mainly because
methods for biochemical and molecular biological analysis of chro-
matin structure are limited [2–9].
To purify speciﬁc genomic regions retaining molecular interac-
tions in vivo, we recently developed the insertional chromatin
immunoprecipitation (iChIP) technology to identify molecules
interacting with a given genomic region of interest in vivo [9,10].
Basically, iChIP consists of locus tagging by insertion of the recog-
nition sequences of an exogenous DNA-binding molecule such as
LexA and afﬁnity puriﬁcation of the tagged DNA-binding protein.
iChIP has been combined with downstream analyses such as mass
spectrometry (MS) (iChIP-MS) to identify proteins and RT-PCR
(iChIP-RT-PCR) to identify RNA [10,11]. Although iChIP is a power-
ful technique to purify speciﬁc genomic regions, it requires inser-
tion of the recognition sequences of an exogenous DNA-binding
molecule by gene targeting or other methods.Recent development of engineered DNA-binding molecules has
enabled us to design and generate molecules binding to a given
DNA sequence. Such engineered DNA-binding molecules include
zinc-ﬁnger proteins [12], transcription activator-like (TAL) proteins
[13], and the CRISPR (clustered regularly interspersed short palin-
dromic repeats) system consisting of a catalytically inactive form
of Cas9 endonuclease (dCas9) and small guide RNA (gRNA) [14].
These molecules have opened a way to tag a speciﬁc genomic locus
without inserting exogenous DNA sequences.
Among others, the CRISPR system provides a ﬂexible and inex-
pensive way to target speciﬁc genomic regions [15]. The CRISPR
system is acquired immunity machinery in bacteria and archaea
to confer resistance to foreign DNA elements [16] and uses gRNA
which base-pairs with the target DNA sequence to cleave foreign
DNA elements [17]. RNA-guided cleavage of foreign DNA elements
requires only a single gene encoding the Cas9 protein and a syn-
thetic gRNA [18–21]. The CRISPR system was successfully used
for RNA-guided genome editing [22–28]. Recently, dCas9 and gRNA
were used to speciﬁcally repress expression of target genes [14].
Here, we established a novel method, engineered DNA-binding
molecule-mediated chromatin immunoprecipitation (enChIP), for
puriﬁcation of speciﬁc genomic regions. In enChIP, speciﬁc geno-
mic regions are immunoprecipitated with antibody against a
tag(s), which is fused to an engineered DNA-binding molecule rec-
ognizing an endogenous DNA sequence in the genomic regions of
interest. For this purpose, we used dCas9, which binds to a speciﬁc
DNA sequence when a gRNA is co-expressed [14]. enChIP mediated
by the CRISPR system efﬁciently enriched the targeted endogenous
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ﬁed proteins associated with those loci. enChIPenChIP using the
CRISPR systemwould be a convenient and useful tool for dissecting
chromatin structure of genomic regions of interest.2. Materials and methods
2.1. Cell culture
293T cells were maintained in DMEM (Wako) supplemented
with 10% fetal calf serum (FCS).
2.2. Plasmids
The plasmid encoding hCas9 D10A was purchased from Add-
gene (#41816) [22]. To construct dCas9, the H840A mutation
was introduced into hCas9 D10A with QuickChange Site-Directed
Mutagenesis Kit (Agilent Technologies). The coding sequence of
dCas9 (D10A/H840A) was cleaved and ligated into the p3XFLAG-
CMV-7.1 vector (Sigma-Aldrich) to generate 3xF-dCas9/pCMV-
7.1. An expression vector of guide RNA was constructed as previ-
ously described [22]. Two oligo nucleotides 50-TTTCTTGGCTTTATA-
TATCTTGTGGAAAGGACGAAACACCGCGGGGGCGCTGGGCTGTCC-30
and 50-GACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAACGGA-
CAGCCCAGCGCCCCCGC-30 were annealed and extended to make
a 100 bp double-stranded DNA fragment using Phusion polymer-
ase (New England Biolabs). The fragment was puriﬁed after aga-
rose electrophoresis and subjected to Gibson assembly (New
England Biolabs) with the linearized gRNA cloning vector (Addgene
#41824) [22] to generate gRNA-hIRF-1 #12, the expression vector
of the gRNA targeting the human IRF-1 locus. The expression vector
of a 3xFLAG-tagged LexA DNA-binding domain, 3xFNLDD, was de-
scribed previously [29].
2.3. enChIP-real-time PCR
3  106 of 293T cells in 10-cm tissue culture plates were trans-
fected with 2 lg of 3xF-dCas9/pCMV-7.1 and 2 lg of gRNA cloning
vector or gRNA-hIRF-1 #12 with Lipofectamine 2000 (Invitrogen).
On the following day, cells were replated into 15-cm tissue culture
plates. Two days after transfection, cells were ﬁxed with 1% form-
aldehyde at 37 C for 5 min. The chromatin fraction was extracted
and fragmented by sonication (the average length of fragments
was about 2 kb) as described previously [10]. The sonicated chro-
matin in Sonication Buffer with 1% Triton X-100 was pre-cleared
with 15 lg of normal mouse IgG (Santa Cruz Biotechnology) conju-
gated to 150 ll of Dynabeads-Protein G (Invitrogen) and subse-
quently incubated with 15 lg of anti-FLAG M2 Ab (Sigma–
Aldrich) conjugated to 150 ll of Dynabeads-Protein G at 4 C over-
night. The Dynabeads were washed twice each with 1 ml of Low
Salt Wash Buffer (20 mM Tris, pH 8.0, 150 mM NaCl, 2 mM EDTA,
1% TritonX-100, 0.1% SDS), High Salt Wash Buffer (20 mM Tris,
pH 8.0, 500 mM NaCl, 2 mM EDTA, 1% TritonX-100, 0.1% SDS), LiCl
Wash Buffer (10 mM Tris, pH 8.0, 250 mM LiCl, 1 mM EDTA, 0.5%
IGEPAL-CA630, 0.5% sodium deoxycholate), and TE Buffer (10 mM
Tris, pH 8.0, 1 mM EDTA). The Dynabeads were suspended in
285 ll of TE and 12 ll of 5 M NaCl and incubated at 65 C overnight
for reverse crosslink. After RNase A treatment at 37 C for 1 h, Pro-
teinase K treatment was done at 45 C for 2 h. Subsequently, DNA
was puriﬁed by phenol/chloroform treatment and used as template
for real-time PCR with SYBR Select PCR system (Applied Biosys-
tems) using the Applied Biosystems 7900HT Fast Real-Time PCR
System. PCR cycles were as follows: heating at 50 C for 2 min fol-
lowed by 95 C for 10 min; 40 cycles of 95 C for 15 s and 60 C for
1 min. The primers used in this experiment are hIRF1-prom-F(27310): 50-cgcctgcgttcgggagatatac-30; hIRF1-prom-R1 + 2
(27312): 50-ctgtcctctcactccgccttgt-30; hSox2-prom-F (27222): 50-
attggtcgctagaaacccatttatt-30; and hSox2-prom-R (27223): 50-
ctgccttgacaactcctgatacttt-30.
2.4. enChIP–MS
For the enChIP–MS analysis, the enChIP procedure was per-
formed as described for enChIP-real-time PCR with 6  106 cells
for transfection, 30 lg of Abs and 300 lg of Dynabeads-Protein G.
TBS Buffer (50 mM Tris, pH 7.5, 150 mM NaCl) with 0.1% IGEPAL
CA-630 was used instead of TE in the ﬁnal step of washing proce-
dure. The immunoprecipitants were eluted by incubating with
200 ll of 3xFLAG peptide (Sigma–Aldrich) (500 lg/ml) in TBS with
0.1% IGEPAL CA-630 at 37 C for 20 min. The eluted samples were
precipitated by isopropanol. The precipitants were suspended in
40 ll of 2 sample buffer, incubated at 100 C for 30 min for re-
verse-crosslinking and denaturation of proteins, and subjected to
SDS–PAGE. The proteins were visualized by Coumassie Brilliant
Blue (CBB) staining. Protein bands were excised and analyzed using
a nanoLC–MS/MS system, composed of LTQ Orbitrap Velos (Ther-
mo Fisher Scientiﬁc) coupled with nanoLC (Advance, Michrom Bio-
Resources) and HTC-PAL autosampler (CTC Analytics) at DNA-chip
Development Center for Infectious Diseases (RIMD, Osaka
University).3. Results
3.1. Scheme of enChIP
In order to isolate speciﬁc genomic regions retaining molecular
interactions and identify associated molecules, we established a
novel method, enChIP. The scheme of this system is as follows
(Fig. 1):
(i) A DNA-binding molecule/complex (DB) is generated to
recognize DNA sequence in a genomic region of interest (Fig. 1).
This can be achieved by utilizing technologies such as engineered
zinc-ﬁnger proteins [12], TAL proteins [13], and the CRISPR system
consisting of dCas9 together with gRNA [14]. The engineered DB is
fused with a tag(s) and the nuclear localization signal (NLS)
(Fig. 1A), and expressed into the cell to be analyzed.
(ii) The resultant cell is stimulated and crosslinked with formal-
dehyde or other crosslinkers, if necessary. This process crosslinks
proteins, RNA, DNA and other molecules interacting with the
genomic region of interest.
(iii) The cell is lysed, and DNA is fragmented by sonication or di-
gested with nucleases such as restriction enzymes.
(iv) The complexes including the engineered DB are subjected to
afﬁnity puriﬁcation such as immunoprecipitation.
(v) The isolated complexes retain molecules interacting with
the genomic region of interest. Reverse crosslinking and
subsequent puriﬁcation of DNA, RNA, proteins, or other molecules
allow identiﬁcation and characterization of these molecules
(Fig. 1B).
3.2. Isolation of endogenous loci by enChIP
To show the feasibility of this system, dCas9 was fused with
3xFLAG tag and NLS (3xF-dCas9) (Fig. 1A), and transiently
expressed into a human embryonic kidney-derived 293T cells
together with the negative control empty gRNA cloning vector
or gRNA-hIRF-1 #12 targeting the human IRF-1 locus. Expression
of 3xF-dCas9 was conﬁrmed by immunoblot analysis (Fig. 2A).
Cells were crosslinked with formaldehyde, and crosslinked
3xFLAG tag
NLS
dCas93xF-dCas9
DNA-binding proteins 
Crosslink (if necessary)
Fragmentation
IP with anti-FLAG Ab
Reverse crosslink
DNA analysis
RNA analysis
Protein analysis
A
B
Interacting genomic regions
RNA
gRNA
Fig. 1. Scheme of engineered DNA-binding molecule-mediated chromatin immu-
noprecipitation (enChIP) using the CRISPR system consisting of dCas9 and gRNA. (A)
The system is composed of a fusion protein, 3xF-dCas9, consisting of 3xFLAG-tag,
dCas9, and the nuclear localization signal (NLS) of SV40 T-antigen, and a guide RNA
(gRNA). (B) The 3xF-dCas9 and gRNA is expressed in appropriate cells. The cells are
crosslinked, if necessary, lysed, and fragmented by sonication or other methods. The
complexes are immunoprecipitated with anti-FLAG Ab, and crosslink is reversed
when crosslinkers are used. Molecules (DNA, RNA, proteins, and others) associated
with the target genomic region are isolated and characterized.
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Fig. 2. (A) Expression of 3xF-dCas9. The expression vector of 3xF-dCas9 or the
control 3xFNLDD protein was transiently transfected into 293T cells. Nuclear
extracts were prepared and subjected to immunoblot (IB) analysis with anti-FLAG
Ab. Coumassie Brilliant Blue (CBB) staining is shown as a protein loading control. (B)
Isolation of the IRF-1 locus by enChIP with 3xF-dCas9 and gRNA. Real-time PCR
analysis of chromatin complexes isolated by enChIP using 3xF-dCas9 and gRNA. The
error bar represents the range of duplicate experiments. (C) Protein complexes
puriﬁed by enChIP were subjected to SDS–PAGE followed by CBB staining. The gel
was cut into ﬁve pieces and subjected to mass spectrometry.
134 T. Fujita, H. Fujii / Biochemical and Biophysical Research Communications 439 (2013) 132–136chromatin was fragmented by sonication. Subsequently, com-
plexes containing 3xF-dCas9 were immunoprecipitated with
anti-FLAG M2 Ab. Real-time PCR showed that the IRF-1 locus
was speciﬁcally detected in the immunoprecipitants prepared
from 293T cells transfected with gRNA-hIRF-1 #12 but not in
those from 293T cells transfected with control gRNA cloning
vector. 7.7% of input genomic DNA was immunoprecipitated from
cells transfected with gRNA-hIRF-1 #12 (Fig. 2C). In contrast,
marginal signals were detected for the irrelevant Sox2 locus.
These results showed that enChIP with 3xF-dCas9 in the presence
of speciﬁc gRNA can speciﬁcally and efﬁciently isolate target
genomic regions.3.3. Identiﬁcation of proteins associated with endogenous loci by
enChIP–MS
Next, enChIP–MS was used to perform non-biased search for
proteins associated with the IRF-1 locus. 6  106 cells were trans-
fected with 3xF-dCas9 and gRNA-hIRF-1 #12. 2 days after transfec-
tion, cells were harvested and subjected to enChIP followed by
elution with 3xFLAG peptide. Eluate was reverse-crosslinked and
subjected to SDS–PAGE. After staining with CBB, proteins were ex-cised for MS analysis (Fig. 2C). We detected many proteins associ-
ated with the IRF-1 locus (Table 1, Supplemental Table 1). The list
contained histones as expected. The list also contained various pro-
teins including metabolic enzymes, RNA helicases, and others.
These data clearly showed that it is feasible to identify proteins
interacting with endogenous genomic regions by enChIP–MS using
the CRISPR system.4. Discussion
In this study, we developed enChIP for puriﬁcation of speciﬁc
genomic regions retaining molecular interactions in vivo for non-
biased identiﬁcation of binding molecules using the CRISPR system
(Fig. 1). We showed that enChIP is able to isolate the endogenous
IRF-1 locus (Fig. 2B). enChIP–MS enabled us to detect known and
novel proteins interacting with the IRF-1 locus (Table 1, Supple-
mental Table 1). The list of detected proteins included histones,
metabolic enzymes, RNA helicases, and others. Many of these pro-
teins were also detected in iChIP-MS (T.F. and H.F., unpublished
data), suggesting that enChIP–MS can also identify relevant
Table 1
Examples of proteins detected in enChIP–MS.
Protein
Histones: H1, H2A, H2B, H3, H4
Histone-binding protein RBBP7
Metabolic enzymes: pyruvate kinase isoenzymes M1/M2, alpha-enolase, fatty
acid synthase, creatinin kinase B, fructose-bisphosphate aldolase A, poly
[ADP-ribose] polymerase, peroxiredoxin-1/2, phosphoglycerate kinase 1,
L-lactate dehydrogenase B
RNA helicases: DDX1, DDX3X, DDX6, DDX17, DDX21, DDX39B
Elongation factors: 1-a, 1-c, 1-d, 2
Tubulins: a-1B, b-5, b-4B
Eukaryotic translation initiation factors
Peptidyl-prolyl cis–trans isomerases: A, FKBP4
Actin and actin-related proteins: actin-5C, actin-related protein 2/3 complex
subunit 4, actin-related protein 3B
Nucleolin
Ribosomal proteins
Polyadenylate-binding protein 1
T-complex proteins
Heat shock proteins: HSP7C, HSP70-1A/1B, HSP70-4, HSP90-a, HSP90-b,
HS105
All of identiﬁed proteins are shown in Supplemental Table 1.
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tin-interacting proteins, which is beneﬁcial for comprehensive
understanding of chromatin biology. In addition, the results
showed that enChIP–MS would be useful for non-biased identiﬁca-
tion of proteins associated with a given genomic locus in vivo. It
would be interesting future issues to investigate the functions of
newly identiﬁed chromatin-binding proteins.
We recently developed iChIP, which is a method to biochemi-
cally isolate genomic regions of interest [9,11]. iChIP has been suc-
cessfully used to directly identify proteins, RNA and DNA bound to
speciﬁc genomic regions in vivo [10,30]. One drawback of iChIP is
that it is necessary to insert the recognition sequences of an exog-
enous DNA-binding molecule such as LexA into the genomic re-
gions of interest. In this regard, enChIP does not require insertion
of recognition sequences of exogenous DNA-binding proteins,
making the procedure much more straightforward. The yield of
isolated genomic regions in iChIP was about 15% of input genomic
DNA [29]. In this regard, the yield of isolated genomic regions in
enChIP using the CRISPR system was 7.7% of input genomic DNA
(Fig. 2C). Although the yield for enChIP using the CRISPR system
was about half of that for iChIP, considering that enChIP can isolate
both alleles in the genome whereas iChIP can isolate only the
tagged allele, the expected total amounts of the isolated genomic
regions would be comparable between these two approaches for
genomic regions in autosomes. Importantly, we could show that
enChIP–MS using the CRISPR system successfully identiﬁes pro-
teins associated with the isolated loci.
Recently, proteomics of isolated chromatin (PICh) has been
developed as a novel technique to isolate speciﬁc genomic regions
retaining molecular interaction [8]. PICh utilizes speciﬁc biotinyla-
ted nucleic acid probes such as locked nucleic acids (LNAs) that
hybridize target genomic regions and isolates the regions using
streptavidin beads to analyze interacting proteins. It has been re-
ported that proteins associated with telomeres can be identiﬁed
by PICh. However, it has not been shown if PICh can be used for
identiﬁcation of proteins associated with low copy number loci.
In this regard, we could successfully show that endogenous low
copy number loci can be puriﬁed by enChIP. In addition, we could
show that associated proteins can be identiﬁed by MS, showing the
utility of enChIP. enChIP can be combined with many different
downstream analytical methods. For example, combination of en-
ChIP with microarray analysis (enChIP-chip) or RNA-Seq analysis
(enChIP-RNA-Seq) would enable us to perform non-biased search
for RNA species associated with a given genomic region. enChIPcan also be combined with genomic PCR to detect interactions be-
tween given loci or next generation sequencing (enChIP-Seq) to
perform non-biased search for interactions between genomic re-
gions in a genome-wide scale.
In summary, enChIP is a novel technology to isolate speciﬁc
genomic regions for non-biased search for interacting molecules.
Because it is very easy to generate gRNA targeting speciﬁc genomic
regions, enChIP using the CRISPR system would be a convenient
way to perform enChIP analysis. enChIP might facilitate under-
standing of molecular mechanisms of a broad range of biological
phenomena involving genome functions.
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